TSTickerStar
Company alerts/AEMD
AEMD company alerts

AEMD updates worth following

TickerStar monitors official filings, investor releases, earnings, and call updates for AEMD. Subscribe to AEMD alerts to receive concise, source-linked alerts when TickerStar detects a meaningful company update.

Official-source feed

Recent AEMD alert previews

TickerStar filters routine noise and surfaces investor-relevant filings, releases, earnings, and call updates.

Equity offeringSEC filing

Aethlon Medical Registers Additional 100,000 Shares Under 2020 Equity Incentive Plan

Aethlon Medical, Inc. filed a Form S-8 to register 100,000 additional shares of common stock under its 2020 Equity Incentive Plan, as amended. The additional shares were authorized by a stockholder-approved amendment to the 2020 Plan on October 1, 2026. The company notes three recent reverse stock splits: a 1-for-8 split effective June 6, 2025, a 1-for-10 split effective October 16, 2025, and a 1-for-5 split effective July 31, 2026, with share counts under the plan adjusted accordingly. This registration adds to...

Read source-backed brief
SEC filingSEC filing

AEMD 10-Q filed 2026-11-12 | Key takeaways

AEMD filed its 10-Q; the most relevant disclosure change is added Proposed Merger with North Immunology: On September 17, 2026, Aethlon entered a two-step merger agreement with North Immunology, Inc. and two wholly owned subsidiaries; the combined company is expected to operate under the name North Immunology, Inc. and focus on North Immunology's pipeline led by.

Read source-backed brief
Company updateOfficial company source

Aethlon Medical 8-K: Authorized common shares increased from 20,000,000 to 200,000,000

Aethlon Medical filed an 8-K reporting that, following stockholder approval at the 2026 Annual Meeting on October 1, 2026, an amendment to the Company's Articles of Incorporation increasing authorized common stock from 20,000,000 to 200,000,000 shares became effective on October 7, 2026. The Certificate of Amendment (Exhibit 3.1) was filed with the Nevada Secretary of State on October 8, 2026. The filing does not disclose any issuance of shares, a planned financing, or financial results.

Read source-backed brief